← SEC 公告列表 | INMD SEC 公告 | InMode（INMD）

重大事件 外國發行人報告 6-K 2026-08-03

InMode股東會四項議案全數通過 重選董事及續聘核數師

於 SEC 網站開啟原文

AI 繁中摘要

InMode Ltd.（納斯達克上市以色列醫療美容設備公司）於2026年8月3日向美國證交會提交6-K表格，匯報於7月30日舉行的股東周年大會結果。會上四項議案全部獲得通過，反映公司治理安排順利延續。✅ 會議重點如下： 1️⃣ 重選Hadar Ron博士為第一類董事，任期至2029年股東周年大會為止。 2️⃣ 續聘Kesselman & Kesselman會計師事務所（普華永道國際成員所）為截至2026年12月31日止財政年度的獨立核數師，服務至2027年股東周年大會。 3️⃣ 批准根據2018年激勵計劃，向三名非執行董事授出合共6,000股限制性股票單位（RSU）：Shlomo Nass博士、Hadar Ron博士及Nadav Kenneth先生各獲2,000股；其中一半將於2027年2月15日歸屬，餘下一半於2028年2月15日歸屬，前提是他們在歸屬日期仍持續服務。 4️⃣ 批准董事會特別委員會的薪酬條款。 會議記錄日期為2026年6月26日，當日已發行在外普通股共57,544,172股。出席會議（親身或委託代表）的股份為31,479,861股，相當於約54.71%，達到法定人數。根據以色列《公司法》及公司章程，上述議案均符合所需大多數票，正式通過。 對投資者而言，今次屬常規企業管治事項，沒有涉及新業務或財務預測，預期不會對公司營運或股價構成直接影響。然而，核數師續任及董事激勵計劃通過，有助維持管治穩定性。📊
展開英文正文 
6-K
1
zk2635811.htm
6-K

 
 
 
 

 
 
 

 
 

 SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, D.C. 20549

 
 

 FORM 6-K

 
 

 REPORT OF FOREIGN PRIVATE ISSUER
 PURSUANT TO RULE 13In a-16 OR 15d-16 OF
 THE SECURITIES EXCHANGE ACT OF 1934

 
 

 For the month of August 2026

 
 

 
 

 INMODE LTD.

 
 

 (Exact name of registrant as specified in its charter)

 
 

 Tavor Building, Sha’ar Yokneam

 P.O. Box 533

 Yokneam 2069206 Israel

 (Address of Principal Executive Offices)

 
 

 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 
 

 

 
 
 Form 20-F ☒            Form 40-F ☐ 

 
 

 
 
 

 Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
 Securities Exchange Act of 1934:

 
 

 

 
 
 Yes ☐        No ☒

 
 

 
 
 

 
 
 

 

 
 

 Further to its Form 6-K, dated June 18, 2026, InMode Ltd. (the “Company”) announces that on July 30, 2026, the Company held its Annual
 General Meeting of Shareholders (the “Meeting”). At the Meeting, the Company’s shareholders voted on the following 4 proposals:

 
 

 

 
 (1)
 
 To re-elect Dr. Hadar Ron to serve as a Class I director of the Company, and to hold office until the annual general meeting of shareholders to be held in 2029 and until her successor is duly elected and qualified, or until her earlier
 resignation or retirement.

 
 

 
 
 

 

 
 (2)
 
 To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member of PricewaterhouseCoopers International Limited, as the Company’s independent auditors for the fiscal year ending December 31, 2026,
 and its service until the annual general meeting of shareholders to be held in 2027.

 
 

 
  

 

 
 (3)
 
 To approve the grant of a total of 6,000 restricted share units under the Company’s 2018 Incentive Plan to the following non-executive directors: Dr. Shlomo Nass (2,000 RSUs), Dr. Hadar Ron (2,000 RSUs) and Mr. Nadav Kenneth (2,000 RSUs),
 half of which shall vest on February 15, 2027, and the remaining half of which shall vest on February 15, 2028, subject to their continued service on the date of vesting.

 
 

 
  

 

 
 (4)
 
 To approve the compensation terms of the Special Committee of the Board, as set forth in Proposal 4 of the Proxy Statement dated June 18, 2026.

 
 

 
 
 

 Each of the proposals was described in more detail in the Company’s proxy statement for the Meeting that was attached as Exhibit 99.1 to a Report of Foreign Private Issuer on
 Form 6-K furnished to the Securities and Exchange Commission on June 18, 2026. On June 26, 2026, the record date for the Meeting (the “Record Date”), there were 57,544,172 ordinary shares issued and
 outstanding. At the Meeting, there were present in person or by proxy, 31,479,861 of the Company’s outstanding ordinary shares, representing approximately 54.71% of the Company’s ordinary shares issued and outstanding as of the Record Date. Under the
 Company’s Articles of Association, the Meeting was properly convened, and a quorum was present.

 
 

 Based on the voting results and the majority requirements for the proposals under the Israeli Companies Law and the Company’s Articles of Association, each of Proposals 1, 2, 3
 and 4 was approved.

 
 

 This Form 6-K is hereby incorporated by reference into all effective registration statements filed by the Company under the Securities Act of 1933, as amended.

 
 

 
 
 

 

 
 
 

 

 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
 authorized.

 
 

 

 
  
 
 InMode Ltd.

 
 

 
  
  
 

 
  
 
 By: /s/ Moshe Mizrahy

 
 

 
  
 
 Moshe Mizrahy

 
 

 
  
 
 Chief Executive Officer

 
 

 
 
 

 Dated August 3, 2026